115 related articles for article (PubMed ID: 29454280)
1. 8-Chrysoeriol, as a potential BCL-2 inhibitor triggers apoptosis of SW1990 pancreatic cancer cells.
Zhang Y; Li Z; Min Q; Palida A; Zhang Y; Tang R; Chen L; Li H
Bioorg Chem; 2018 Apr; 77():478-484. PubMed ID: 29454280
[TBL] [Abstract][Full Text] [Related]
2. The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2.
Li Z; Zhang Y; Chen L; Li H
Food Funct; 2018 May; 9(5):3018-3027. PubMed ID: 29770817
[TBL] [Abstract][Full Text] [Related]
3. A novel derivative of valepotriate inhibits the PI3K/AKT pathway and causes Noxa-dependent apoptosis in human pancreatic cancer cells.
Yan YY; Shi KY; Teng F; Chen J; Che JX; Dong XW; Lin NM; Zhang B
Acta Pharmacol Sin; 2020 Jun; 41(6):835-842. PubMed ID: 32047260
[TBL] [Abstract][Full Text] [Related]
4. Solasodine, Isolated from
Fan Y; Li Z; Wu L; Lin F; Shao J; Ma X; Yao Y; Zhuang W; Wang Y
Drug Des Devel Ther; 2021; 15():1509-1519. PubMed ID: 33888977
[TBL] [Abstract][Full Text] [Related]
5. Pro-apoptotic activity of BH3-only proteins and BH3 mimetics: from theory to potential cancer therapy.
Hartman ML; Czyz M
Anticancer Agents Med Chem; 2012 Oct; 12(8):966-81. PubMed ID: 22263800
[TBL] [Abstract][Full Text] [Related]
6. The Opposite Effect of L-kynurenine and Ahr Inhibitor Ch223191 on Apoptotic Protein Expression in Pancreatic Carcinoma Cells (Panc-1).
Leja-Szpak A; Góralska M; Link-Lenczowski P; Czech U; Nawrot-Porąbka K; Bonior J; Jaworek J
Anticancer Agents Med Chem; 2019; 19(17):2079-2090. PubMed ID: 30987575
[TBL] [Abstract][Full Text] [Related]
7. Molecular docking studies of bioactive compounds from Annona muricata Linn as potential inhibitors for Bcl-2, Bcl-w and Mcl-1 antiapoptotic proteins.
Mohamad Rosdi MN; Mohd Arif S; Abu Bakar MH; Razali SA; Mohamed Zulkifli R; Ya'akob H
Apoptosis; 2018 Jan; 23(1):27-40. PubMed ID: 29204721
[TBL] [Abstract][Full Text] [Related]
8. Bcl-xL inhibition by molecular-targeting drugs sensitizes human pancreatic cancer cells to TRAIL.
Hari Y; Harashima N; Tajima Y; Harada M
Oncotarget; 2015 Dec; 6(39):41902-15. PubMed ID: 26506422
[TBL] [Abstract][Full Text] [Related]
9. Luteolin from Flos Chrysanthemi and its derivatives: New small molecule Bcl-2 protein inhibitors.
Zheng CH; Zhang M; Chen H; Wang CQ; Zhang MM; Jiang JH; Tian W; Lv JG; Li TJ; Zhu J; Zhou YJ
Bioorg Med Chem Lett; 2014 Oct; 24(19):4672-4677. PubMed ID: 25193233
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative effect of resveratrol in pancreatic cancer cells.
Cui J; Sun R; Yu Y; Gou S; Zhao G; Wang C
Phytother Res; 2010 Nov; 24(11):1637-44. PubMed ID: 21031621
[TBL] [Abstract][Full Text] [Related]
11. Effect of Resveratrol Treatment on Human Pancreatic Cancer Cells through Alterations of Bcl-2 Family Members.
Ratajczak K; Glatzel-Plucińska N; Ratajczak-Wielgomas K; Nowińska K; Borska S
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770968
[TBL] [Abstract][Full Text] [Related]
12. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
Enyedy IJ; Ling Y; Nacro K; Tomita Y; Wu X; Cao Y; Guo R; Li B; Zhu X; Huang Y; Long YQ; Roller PP; Yang D; Wang S
J Med Chem; 2001 Dec; 44(25):4313-24. PubMed ID: 11728179
[TBL] [Abstract][Full Text] [Related]
13. Decoding the antineoplastic efficacy of Aplysin targeting Bcl-2: A de novo perspective.
Shakeel E; Sharma N; Akhtar S; Khan MKA; Lohani M; Siddiqui MH
Comput Biol Chem; 2018 Dec; 77():390-401. PubMed ID: 30469054
[TBL] [Abstract][Full Text] [Related]
14. Hyperoside induces apoptosis and inhibits growth in pancreatic cancer via Bcl-2 family and NF-κB signaling pathway both in vitro and in vivo.
Li Y; Wang Y; Li L; Kong R; Pan S; Ji L; Liu H; Chen H; Sun B
Tumour Biol; 2016 Jun; 37(6):7345-55. PubMed ID: 26676634
[TBL] [Abstract][Full Text] [Related]
15. Development of 3-phenyl-N-(2-(3-phenylureido)ethyl)-thiophene-2-sulfonamide compounds as inhibitors of antiapoptotic Bcl-2 family proteins.
Yang C; Chen S; Zhou M; Li Y; Li Y; Zhang Z; Liu Z; Ba Q; Li J; Wang H; Yan X; Ma D; Wang R
ChemMedChem; 2014 Jul; 9(7):1436-52. PubMed ID: 24782462
[TBL] [Abstract][Full Text] [Related]
16. Short-chain C6 ceramide sensitizes AT406-induced anti-pancreatic cancer cell activity.
Zhao X; Sun B; Zhang J; Zhang R; Zhang Q
Biochem Biophys Res Commun; 2016 Oct; 479(2):166-172. PubMed ID: 27562715
[TBL] [Abstract][Full Text] [Related]
17. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer.
Mortenson MM; Galante JG; Gilad O; Schlieman MG; Virudachalam S; Kung HJ; Bold RJ
J Cell Biochem; 2007 Dec; 102(5):1171-9. PubMed ID: 17960583
[TBL] [Abstract][Full Text] [Related]
18. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer.
Wang P; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Shen YH; Liu LM
Integr Cancer Ther; 2010 Mar; 9(1):50-8. PubMed ID: 20308085
[TBL] [Abstract][Full Text] [Related]
19. CdSe/ZnS quantum dots induce photodynamic effects and cytotoxicity in pancreatic cancer cells.
He SJ; Cao J; Li YS; Yang JC; Zhou M; Qu CY; Zhang Y; Shen F; Chen Y; Li MM; Xu LM
World J Gastroenterol; 2016 Jun; 22(21):5012-22. PubMed ID: 27275093
[TBL] [Abstract][Full Text] [Related]
20. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
